Nectin Therapeutics
PrivateLast Round
Series A
May 6, 2024
Total Funding Raised
$41M
Company Overview
Nectin Therapeutics is a biotechnology company that develops next-generation immuno-oncology therapies to treat solid and hematological malignancies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nectin Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Nectin Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 6, 2024 | ||||
| VC Round | May 16, 2023 | ||||
| Series A Extension | Nov 30, 2022 | ||||
| VC Round | Mar 7, 2022 | ||||
| Series A | Jul 16, 2020 |
Key People
Founding team and executive leadership
Nectin Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Biotech Fund | VC Round, Series A Extension |
| Peregrine Ventures (California) | Series A Extension |
| Myeloma Investment Fund | Series A, VC Round |
| Integra Holdings | Series A, VC Round, Series A Extension |
| aMoon | Series A Extension |
| Cancer Focus Fund | Series A, Series A Extension, VC Round |
| Guangzhou Sino-Israel Bio-Industry Investment Fund | Series A |
Nectin Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nectin Therapeutics's valuation, stock price, and market status.
